COMMUNIQUÉS West-GlobeNewswire

Kamada Announces Interim Results from Phase 2 Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection
08/01/2018
Kamada’s IV AAT Demonstrated Favorable Safety and Tolerability Profile in 10 Patients During First Six Months of Treatment, Consistent with Previously Observed Results in Other Indications Next Interim Report Expected [...]
Microbot Medical Enters into Agreement to Acquire Novel Technology to Enhance Existing Technology Platforms and Strengthen Patent Portfolio
08/01/2018
HINGHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer
08/01/2018
HOUSTON, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company’s clinical site investigator has initiated patient recruitment for the second dosing group for the Prolanta™ Phase [...]
Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Endpoints in Two Phase 2 Clinical Trials for Common Warts
08/01/2018
Highly statistically significant results on all primary and secondary endpoints Statistical significance seen as early as day 28, after 4 weeks of treatment in WART-203 If approved, A-101 45% would be the first FDA [...]
NeuroMetrix Reports Preliminary 2017 Financial Highlights
08/01/2018
WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported preliminary financial highlights for the fourth quarter and for the full year 2017. GAAP revenue for the fourth quarter [...]
Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance
08/01/2018
Company Issues Preliminary Fourth Quarter and Full Year 2017 Expectations In Conjunction with J.P. Morgan Healthcare Conference Participation Preliminary Fourth Quarter 2017 Expectations Fourth quarter revenue expected [...]
AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue
08/01/2018
Q4 Revenue will be at least $16.5 million, representing 45% growth over prior year 2017 Revenue will be at least $60.0 million, representing 46% growth over prior year ALACHUA, Fla., Jan. 08, 2018 (GLOBE NEWSWIRE) -- [...]
ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology
08/01/2018
LEIDEN, the Netherlands, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext & NASDAQ: [...]
Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year
08/01/2018
DANVERS, Mass. and SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today reported preliminary, unaudited, third quarter [...]
Natus Medical Announces 2018 Annual and First Quarter Financial Guidance
08/01/2018
Announces Fourth Quarter preliminary revenue results Announces Fourth Quarter 2017 Financial Results Conference Call Date PLEASANTON, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) [...]
K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results
08/01/2018
LEESBURG, Va., Jan. 08, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
ChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in Singapore
08/01/2018
IRVINE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN ™ [...]
Avivagen Announces Positive Results from Dairy Cattle Trial
08/01/2018
OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use [...]
Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
08/01/2018
Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’s previous implied guidance range of $345 million to $355 [...]
Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook
08/01/2018
GAITHERSBURG, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced preliminary unaudited 2017 financial results and guidance for 2018. Daniel J. Abdun-Nabi, president and chief [...]
US ARMY Fully Funds Spider Silk Development Contract with Kraig Biocraft Laboratories
08/01/2018
ANN ARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the US ARMY has fully funded its [...]
BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region
08/01/2018
CAMBRIDGE, Mass. and BEIJING, China and SAN DIEGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301
08/01/2018
PALATINE, Ill., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that topline results from clinical study [...]
Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products
08/01/2018
CINCINNATI, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Enable Injections , Inc., developer of the advanced enFuse™ large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has been awarded the [...]

Pages